Enhanced Tumorocidal Effect of Chemotherapy With Preoperative Radiotherapy for Rectal Cancer: Preliminary Results—EORTC 22921
Jean-François Bosset(Université de Franche-Comté), Laurence Collette(GlaxoSmithKline (Belgium)), A. Briffaux(Centre Hospitalier Universitaire de Tours), Laurent Mineur(Institut Sainte Catherine), Alexander Beny(Rambam Health Care Campus), P. Maingon(Maison des Sciences sociales et des Humanités de Dijon), Ljiljana Radošević-Jelić(Oncology Institute of Vojvodina), G. Calais, A. Daban(Université de Poitiers), É. Bardet(Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers)
Cited by 593
Related Papers
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
|The Lancet|2008|1.9k
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
|The Lancet|2002|1.7k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
|New England Journal of Medicine|1997|1.6k